Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil

被引:20
作者
de Araujo-Filho, Joso Alves [1 ,2 ]
Vasconcelos, Arioldo Carvalho, Jr. [1 ]
de Sousa, Eduardo Martins [1 ]
Kipnis, Andre [1 ]
Ribeiro, Elisangela [3 ]
Junqueira-Kipnis, Ana Paula [1 ]
机构
[1] Univ Fed Goias, Inst Patol Trop & Saude Publ, BR-74605050 Goiania, Go, Brazil
[2] Secretaria Saude Estado Goias, Hosp Doencas Tropicais Dr Anuar Auad, BR-74853120 Goiania, Go, Brazil
[3] Assoc Combate Ao Canc Goias, Hosp Araujo Jorge, BR-74605070 Goiania, Go, Brazil
关键词
multi-drug resistant; tuberculosis; interferon-gamma; interleukin-10; MPT-51; GlcB;
D O I
10.1016/j.tube.2008.06.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Multi-drug resistant pulmonary tuberculosis (MDR-TB) may result from either insufficiency of the host cellular immune response or mycobacterial. mechanisms of resistance. Mycobacterium tuberculosis-specific CD8(+) and CD4(+) T lymphocytes from MDR-TB patients are poorly studied. The aim of this study was to evaluate CD4(+)-IFN-gamma(+), CD4(+)-IL-10(+), CD8(+)IFN-gamma(+) and CD8(+)IL-10(+) cell populations by flow cytometry in non-resistant TB and multi-drug resistant tuberculosis (MDR-TB) patients from mid-central Brazil after stimulation with MPT-51, GlcB and ESAT-6 recombinant antigens from M. tuberculosis in comparison to tuberculin skin test negative (TST) healthy individuals. Non-resistant TB patients present specific cellular responses (CD4 and CD8, both IFN-gamma and IL-10) to GLcB, MPT-51 and ESAT-6; while MDR-TB patients present only CD8(+)IFN-gamma(+) responses to ESAT-6 and CD8(+)IL-10(+) responses to GlcB and ESAT-6. The results show that MDR-TB patients present impaired specific CD4 IFN-gamma and IL-10 responses and increased/normal specific CD8 IFN-gamma and IL-10 responses. This suggests an important role for CD8 function in these patients. (c) 2008 El.sevier Ltd. All rights reserved.
引用
收藏
页码:474 / 481
页数:8
相关论文
共 41 条
[1]
Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis [J].
Achkar, Jacqueline M. ;
Dong, Yuxin ;
Holzman, Robert S. ;
Belisle, John ;
Kourbeti, Irene S. ;
Sherpa, Tsering ;
Condos, Rany ;
Rom, William N. ;
Laal, Suman .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (11) :1291-1293
[2]
Models of the within-host dynamics of persistent mycobacterial infections [J].
Antia, R ;
Koella, JC ;
Perrot, V .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1996, 263 (1368) :257-263
[3]
Barriers to reaching the targets for tuberculosis control:: multidrug-resistant tuberculosis [J].
Blondal, Kai .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2007, 85 (05) :387-390
[4]
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor β (TGF-β) and analysis of TGF-β receptors I and II in active tuberculosis [J].
Bonecini-Almeida, MG ;
Ho, JL ;
Boéchat, N ;
Huard, RC ;
Chitale, S ;
Doo, H ;
Geng, JY ;
Rego, L ;
Lazzarini, LCO ;
Kritski, AL ;
Johnson, WD ;
McCaffrey, TA ;
Silva, JRLE .
INFECTION AND IMMUNITY, 2004, 72 (05) :2628-2634
[5]
Levels of tumour necrosis factor-α and IL-1a in newly diagnosed and multidrug resistant tuberculosis [J].
Çagatay, T ;
Kiran, B ;
Yurt, S ;
Gülbaran, Z ;
Kosar, F ;
Çagatay, P .
RESPIROLOGY, 2005, 10 (03) :290-294
[6]
Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829
[7]
CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217
[8]
Humoral immune responses of tuberculosis patients in Brazil indicate recognition of Mycobacterium tuberculosis MPT-51 and GlcB [J].
Cardoso Almeida, Cristina Melo ;
Vasconcelos, Arioldo C., Jr. ;
Kipnis, Andre ;
Andrade, Ana Lucia ;
Junqueira-Kipnis, Ana Paula .
CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (03) :579-581
[9]
Abnormal production of transforming growth factor β and interferon γ by peripheral blood cells of patients with multidrug-resistant pulmonary tuberculosis in Brazil [J].
Castro, AZ ;
Diaz-Bardalez, BM ;
Oliveira, EC ;
Garcia, RC ;
Afiune, JB ;
Paschoal, IA ;
Santos, LMB .
JOURNAL OF INFECTION, 2005, 51 (04) :318-324
[10]
Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis [J].
Chan, ED ;
Laurel, V ;
Strand, MJ ;
Chan, JF ;
Huynh, MLN ;
Goble, M ;
Iseman, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (10) :1103-1109